Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

The Disease Severity and Clinical Outcomes of the Sars-CoV-2 Variants of Concern

Bibliographic Data

ID22088394
AuthorsLixin Lin (0000-0001-8339-5965, Hong Kong Polytechnic University), Ying Liu (0000-0001-5584-7805, Xiamen University), Xiujuan Tang (Shenzhen Center for Disease Control and Prevention), Daihai He (0000-0003-3253-654X, Hong Kong Polytechnic University, corresponding author)
Year2021
Volume9
Pages775224-775224
Publication date2021-11-30
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2021.775224
PMID34917580
OpenAlexW3217290471
LanguageEN
Citations received15
References cited47

With the continuation of the pandemic, many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have appeared around the world. Owing to a possible risk of increasing the transmissibility of the virus, severity of the infected individuals, and the ability to escape the antibody produced by the vaccines, the four SARS-CoV-2 variants of Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), and Delta (B.1.617.2) have attracted the most widespread attention. At present, there is a unified conclusion that these four variants have increased the transmissibility of SARS-CoV-2, but the severity of the disease caused by them has not yet been determined. Studies from June 1, 2020 to October 15, 2021 were considered, and a meta-analysis was carried out to process the data. Alpha, Beta, Gamma, and Delta variants are all more serious than the wild-type virus in terms of hospitalization, ICU admission, and mortality, and the Beta and Delta variants have a higher risk than the Alpha and Gamma variants. Notably, the random effects of Beta variant to the wild-type virus with respect to hospitalization rate, severe illness rate, and mortality rate are 2.16 (95% CI: 1.19–3.14), 2.23 (95% CI: 1.31–3.15), and 1.50 (95% CI: 1.26–1.74), respectively, and the random effects of Delta variant to the wild-type virus are 2.08 (95% CI: 1.77–2.39), 3.35 (95% CI: 2.5–4.2), and 2.33 (95% CI: 1.45–3.21), respectively. Although, the emergence of vaccines may reduce the threat posed by SARS-CoV-2 variants, these are still very important, especially the Beta and Delta variants

Disease · Mortality rate · Pandemic · Severity of illness · Virus · Animal Virus Infections Studies · Medicine · SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · Internal Medicine · Virology

  • Covid-19 mortality rate determinants in selected Eastern European countries

    Open Access•Marharyta Sobczak, Rafał Pawliczak•BMC Public Health•2022

  • Teamwork Management and Benefit of Telemedicine in Covid-19 Outbreak Control on an Offshore Vessel in the Gulf of Thailand, Songkhla Province, Thailand

    Open Access•Rujjirat Pongpattarapokin, Sarunyou Chusri et al.•International Journal of…•2023

  • Du Niger de Diori Hamani au gouvernement des militaires (1974-1977)

    Open Access•Edmond Jouve, Jingxing Li et al.•Frontiers in Public Health•1978

  • Covid-19 vaccination strategies in settings with limited rollout capacity

    Open Access•Gizem Mayis Bilgin, Kamalini Lokuge et al.•BMC Public Health•2023

  • Global Estimates of Lives and Life-Years Saved by Covid-19 Vaccination During 2020-2024

    Open Access•John P A Ioannidis, Angelo Maria Pezzullo et al.•JAMA Health Forum•2025

  • Modelling of Waning of Immunity and Reinfection Induced Antibody Boosting of Sars-CoV-2 in Manaus, Brazil

    Open Access•Haozhen Wei, Salihu S Musa et al.•International Journal of…•2022

  • Multimorbidity Profiles and Infection Severity in Covid-19 Population Using Network Analysis in the Andalusian Health Population Database

    Open Access•Jonás Carmona‐Pírez, Ignatios Ioakeim‐Skoufa et al.•International Journal of…•2022

  • Seasonality of Covid-19 incidence in the United States

    Open Access•El Hussain Shamsa, Ali Shamsa et al.•Frontiers in Public Health•2023

  • Factors associated with the worsening of Covid-19 symptoms among cohorts in community- or home-isolation care in southern Thailand

    Open Access•Thanit Sila, Wisanuwee Suriyaamorn et al.•Frontiers in Public Health•2024

  • Evolving trend change during the Covid-19 pandemic

    Open Access•Liping Gao, Canjun Zheng et al.•Frontiers in Public Health•2022

  • The first 2 years of Covid-19 in Italy

    Open Access•Pierpaolo Ferrante•Frontiers in Public Health•2022

  • Covid-19 waves in an urban setting 2020–2022

    Open Access•Yi-shuan Elaine Chen, Susan H Gawel et al.•Frontiers in Public Health•2024

  • Mathematical modeling of Sars-CoV-2 variant substitutions in European countries

    Open Access•Víctor López de Rioja, Aida Perramon-Malavez et al.•Frontiers in Public Health•2024

  • Two-year follow-up of the Covid-19 pandemic in Mexico

    Open Access•Antonio Loza, Rosa María Wong-Chew et al.•Frontiers in Public Health•2023

  • Fair and effective vaccine allocation during pandemics

    Open Access•Nezihe Nazli Gul, Saeed Taheri et al.•Social Science & Medicine•2026

  • Rapid Spread of the Sars-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)

    Open Access•Daniela Loconsole, Francesca Centrone et al.•International Journal of…•2021

Unique citing works15
Citations per year0.31
Citation span1978 - 2026 (49)
Citation velocitycurrent
Highly citedNo
Citation typesNeutral: 15

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae